AMSBIO Expands US Operations
News Apr 23, 2014

AMSBIO has announced the opening of a new North American headquarters with executive management facilities in Cambridge, MA for its US subsidiary - AMSBIO LLC.
Commenting on this strategic move, Alex Sim (President, AMSBIO) said “The US is the single largest market for our stem cell and regenerative medicine, glycobiology enzymes / substrates and tissue derived products. Drawing upon our in-depth expertise in extracellular matrices we are able to also provide elegant solutions for studying cell motility, migration, invasion and proliferation”.
He added “Our North American customer base has been growing strongly over recent years. From the new East Coast facility we will provide local informed service and support as well as next day delivery of a comprehensive range of enabling technology products to help improve the productivity of our US customers”.
RELATED ARTICLES
“Lymphoma Micro-reactor” Targets Chemo-Resistant Lymphoma
NewsResearchers have developed a “lymphoma micro-reactor” device that exposes human lymphomas to fluid flow similar to that in the lymphatics and parts of the lymph node.
READ MOREGrafted Brain Organoids Provide Insight into Neurological Disorders
NewsSalk scientists improve the growth of three-dimensional brain models to better understand autism, dementia, schizophrenia.
READ MORENew Process to Differentiate Stem Cells into Nucleus Pulposus-Like Cells
NewsResearchers at Washington University have developed a new way to transform human induced pluripotent stem cells into nucleus pulposus cells, which are the chief component of intervertebral discs.
READ MOREComments | 0 ADD COMMENT
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREEWorld Congress on Advanced Structural and Molecular Biology 2018
Aug 22 - Aug 23, 2018
Login
You must be logged in to post a comment.